Denmark – Pharmaceutical products – Amgros 2027 1.357.b

Opportunity description

Amgros I/S (Amgros) is a partnership with the 5 regions as partners. Amgros wishes to enter into framework agreements for the medicinal products listed in the individual lots below, with a view to supplying the partners’ hospital pharmacies with medicinal products and potentially reselling them to the Faroe Islands and Greenland. Amgros resells the medicinal products to the hospital pharmacies at Amgros’ purchase price with a surcharge. The framework agreements are non-exclusive. The framework agreements are concluded without any purchase obligation, and the hospital pharmacies in the regions are not obliged to use Amgros’ framework agreements. The tender number (lot) covers the following medicinal products: ATC Code: R03DX05 · Generic name: Omalizumab · Dosage form: Solution for injection · Strength: 75 mg · Packaging: Syringe / Pen · Unit value: 16 mg · Quantity in units: 663. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may thus choose to submit a tender for one, several or all tender numbers, and award takes place separately for each individual tender number. A supplier may thus be awarded one, several or all lots. Reference is made to the tender conditions, including regarding the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for patient treatment at public hospitals, where the patient’s needs must be met. One or more of the medicinal products put out to tender are covered by assessments and/or treatment guidelines from the Danish Medicines Council, and the consumption of the various medicinal products may be significantly affected thereby. For a more detailed description, reference is made to the tender conditions and the framework agreement. The tender number (lot) covers the following medicinal products: ATC Code: R03DX05 · Generic name: Omalizumab · Dosage form: Solution for injection · Strength: 150 - 300 mg · Packaging: Syringe / Pen · Unit value: 16 mg · Quantity in units: 549638. Each tender number is considered an independent lot and is tendered independently of the other tender numbers. A supplier may thus choose to submit a tender for one, several or all tender numbers, and award takes place separately for each individual tender number. A supplier may thus be awarded one, several or all lots. Reference is made to the tender conditions, including regarding the submission of tenders under the individual tender numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the tender number is stated, but actual consumption may differ significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for patient treatment at public hospitals, where the patient’s needs must be met. One or more of the medicinal products put out to tender are covered by assessments and/or treatment guidelines from the Danish Medicines Council, and the consumption of the various medicinal products may be significantly affected thereby. For a more detailed description, reference is made to the tender conditions and the framework agreement. Procedure: open. Estimated value: 540,000,000 DKK. Review the original TED notice for the complete requirement, lots, amendments and attachments.